LXS LANXESS Aktiengesellschaft
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. It also offers additives, lubricants, flame retardants, plasticizers, and bromine derivatives for various rubber, plastic and paint, electrical/electronics, and construction industries. In addition, the company provides basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials, as well as paints and coatings. It serves the energy, natural resources, industrial applications, nutrition, health, consumer goods, agriculture, animal health, construction, chemicals, and mobility industries. LANXESS Aktiengesellschaft was founded in 1863 and is headquartered in Cologne, Germany.…
Industry Peers
Specialty ChemicalsKey Statistics
About LANXESS (ETR: LXS)
›
LANXESS (ETR: LXS) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 11,417 employees.
The shares were at 12.03 EUR on 19 November 2026, down 27.3% over 52 weeks. Its 52-week range is 11.03 EUR to 22.02 EUR: the price is 45.4% below the high and 9.1% above the low.
Its market capitalisation is 1.04B EUR. It pays a dividend yielding 0.79% (it pays out 70% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
LANXESS reports return on equity of -16.5%, an operating margin of -2.0% and revenue up 9.6% year over year.
Its debt exceeds its cash by 2.03B EUR, a debt-to-equity ratio of 0.71. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 13 analysts cover the stock, with an average rating of Hold; their mean price target of 14.69 EUR is 22.1% above the current price. The next earnings report is expected on 17 March 2027.